Who is sponsoring NCT04214769?

NCT04214769 is sponsored by Tel-Aviv Sourasky Medical Center.

What drugs are being tested in NCT04214769?

Interventions in NCT04214769: Audiometry and tympanometry, vHIT, VEMP, ENG.

What condition does NCT04214769 study?

NCT04214769 studies Head and Neck Cancer Patients Treated With Radiotherapy.

Is NCT04214769 still recruiting?

NCT04214769 is currently status unknown. Last updated 2 January 2020.

Last reviewed 2020-01-02 · How we verify

NCT04214769

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Radiation Therapy Among Head and Neck Cancer Patients on the Inner Ear Function

Status unknown Last updated 2 January 2020

What this trial tests

trial testing Audiometry and tympanometry, vHIT, VEMP, ENG in Head and Neck Cancer Patients Treated With Radiotherapy in 17 participants. Status unknown.

Timeline

1 March 2020

Primary endpoint
31 August 2021

31 August 2021

Quick facts

Lead sponsor	Tel-Aviv Sourasky Medical Center
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	17
Start date	1 March 2020
Primary completion	31 August 2021
Estimated completion	31 August 2021

Drugs / interventions tested

Audiometry and tympanometry, vHIT, VEMP, ENG

Conditions studied

Head and Neck Cancer Patients Treated With Radiotherapy — all drugs for Head and Neck Cancer Patients Treated With Radiotherapy →

Sponsor

Tel-Aviv Sourasky Medical Center

Who can join

18 and older, any sex, with Head and Neck Cancer Patients Treated With Radiotherapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Aims: 1. To evaluate the effects of radiation therapy on the inner ear, among patients treated with radiation therapy for head and neck cancers using a wide battery of tests (Audiometry and tympanometry, vHIT, VEMP, ENG) ; 2. To correlate the mean total radiation dose to the cochlea with the effects on audiological and vestibular function

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Tel-Aviv Sourasky Medical Center trials

Trials by the same sponsor.

NCT07380737 — Feasibility and Preliminary Effects of the Walking Tall App for Home-Based Gait Training in Parkinson's Disease: A Pilot · NA · recruiting
NCT07104136 — Improving Adherence to COPD Treatments in Primary Care · NA · enrolling by invitation
NCT07327021 — MRI-Guided Neoadjuvant Treatment De-Escalation in Stage II-III TNBC · Phase 2 · recruiting
NCT07191249 — A Phase 2, Multicenter, Open-Label Trial to Evaluate Efficacy and Safety of Subcutaneous (SC) Mosunetuzumab in Previousl · Phase 2 · not yet recruiting
NCT07235332 — Assessing Toxic Metal Exposure From Vegetarian/Vegan, Omnivorous, and Low-carb Diets in Israel. · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04214769 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tel-Aviv Sourasky Medical Center
Last refreshed: 2 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04214769.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing